In 2007 the FDA passed a law which required that new clinical trials conducted in the United States post summaries of their results at within a year of completion at a government web site, or be fined $10,000 a day. Five years later, the British Medical Journal found that four out of five trials covered by the legislation had ignored the reporting requirements and no one was fined for violating the law.
And then there's the International Committee of Medical Journal Editors. It directed that its members never again publish any clinical trial unless its existence had been declared on a publicly accessible registry before the trial began. The result from a subsequent study: the editors had broken their promise: more than half of all trials published in leading journals still weren’t properly registered, and a quarter weren’t registered at all.
No comments:
Post a Comment